BriefTea
Every story in sixty words
Explained in plain English
Wegovy is a brand name for semaglutide, a drug that helps people feel fuller for longer and reduces appetite. It's administered as a weekly injection. The NHS started prescribing it for weight loss to eligible patients in England in 2023, as part of a broader strategy to tackle obesity and related health conditions.
Stories that explain this
NHS weight loss jab patients face regaining weight from JanuaryRelated explainers
The cost of new medicines The NHS and obesity costs Why is there a two-year limit? Weight loss drugs globally Who gets free flu jabs? Do these jabs cause deaths? How do these jabs work? What are weight loss jabs?The full catalogue
Browse every card filed under W →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.